Benzinga's Top Downgrades

Analysts at Sterne Agee downgraded DSW DSW from Neutral to Underperform. The target price for DSW is set to $23. DSW's shares closed at $27.16 on Friday. BMO Capital downgraded Pfizer PFE from Outperform to Market Perform. The target price for Pfizer has been lowered from $34 to $31. Pfizer's shares closed at $30.19 on Friday. Analysts at Canaccord Genuity downgraded AcelRx Pharmaceuticals ACRX from Buy to Hold. The target price for AcelRx Pharmaceuticals has been lowered from $16.00 to $8.00. AcelRx Pharmaceuticals' shares closed at $10.83 on Friday. Deutsche Bank downgraded Lear LEA from Buy to Hold. The target price for Lear has been raised from $100.00 to $103.00. Lear's shares closed at $99.00 on Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!